Skip to main content

Table 1 Drug dosages per dose level

From: Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

Dose level

Ixazomib

orally on days 1, 8, 15

every 4 weeks

Carboplatin

i.v. on days 1,8 and 15

every 4 weeks

1

3 mg

AUC 1.5

2

3 mg

AUC 2

3

4 mg

AUC 2

4

4 mg

AUC 2.5

  1. AUC = area under the curve